FDA promised a ‘lower-cost option’ to EpiPen, but the price isn’t any lower

Re:FDA promised a ‘lower-cost option’ to EpiPen, but the pri... by eiaoa on Wednesday November 28, 2018 @05:43PM (#18556385)

Or, a government could just say...

Why not both? I'm serious. It seems like a good idea to promote competition and put a ceiling on the prices of essential medicines based on the global market. 10% above the lowest price may be a bit aggressive, but something must be done to stop these 10,000% markups we're seeing now.

[ Parent | on HN ]

Re:FDA promised a ‘lower-cost option’ to EpiPen, but the pri... by r00fus on Wednesday November 28, 2018 @05:58PM (#18556490)

Cue pharma & equipment companies complaining about R&D costs for patents and approval processes.

Of course, they still complain and somehow shoehorn busdev & marketing costs into the R&D bucket anyway.

[ Parent | on HN ]

Re:FDA promised a ‘lower-cost option’ to EpiPen, but the pri... by TheSpiceIsLife on Wednesday November 28, 2018 @07:27PM (#18557066)

What R&D costs are there for existing, well established, proven emergency medicines for their current uses?

[ Parent | on HN ]